scholarly journals Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain

Medicines ◽  
2019 ◽  
Vol 6 (3) ◽  
pp. 91 ◽  
Author(s):  
Bista ◽  
Imlach

Trigeminal neuropathic pain is a chronic pain condition caused by damage or inflammation of the trigeminal nerve or its branches, with both peripheral and central nervous system dysfunction contributing to the disorder. Trigeminal pain conditions present with diagnostic and therapeutic challenges to healthcare providers and often require multiple therapeutic approaches for pain reduction. This review will provide the overview of pathophysiology in peripheral and central nociceptive circuits that are involved in neuropathic pain conditions involving the trigeminal nerve and the current therapeutics that are used to treat these disorders. Recent advances in treatment of trigeminal pain, including novel therapeutics that target ion channels and receptors, gene therapy and monoclonal antibodies that have shown great promise in preclinical studies and clinical trials will also be described.

2000 ◽  
Vol 5 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Allan S Gordon

Practitioners are often presented with patients who complain bitterly of facial pain. The trigeminal nerve is involved in four conditions that are sometimes mixed up. The four conditions - trigeminal neuralgia, trigeminal neuropathic pain, postherpetic neuralgia and atypical facial pain - are discussed under the headings of clinical features, differential diagnosis, cause and treatment. This article should help practitioners to differentiate one from the other and to manage their care.


2016 ◽  
Vol 124 (4) ◽  
pp. 962-965 ◽  
Author(s):  
Impreet Gill ◽  
Andrew G. Parrent ◽  
David A. Steven

Cranial nerve (CN) deficits following anterior temporal lobectomy (ATL) are an uncommon but well-recognized complication. The usual CNs implicated in post-ATL complications include the oculomotor, trochlear, and facial nerves. To the authors’ knowledge, injury to the trigeminal nerve leading to neuropathic pain has not been previously described in the literature. This paper presents 2 cases of trigeminal neuropathic pain following temporal lobe resections for pharmacoresistant epilepsy. The possible pathophysiological mechanisms are discussed and the microsurgical anatomy of surgically relevant structures is reviewed.


2020 ◽  
Vol 5;23 (9;5) ◽  
pp. E525-E533
Author(s):  
G. Niraj

Background: Trigeminal neuropathic pain (TNP) can present as a constant, unremitting unilateral facial pain. Current management is based on expert recommendation that includes pharmacologic agents and psychological therapy. However, treatment success with pharmacologic management is poor. We adopted a novel strategy that proved to be effective in providing durable relief. Objectives: Prospectively audit a novel strategy in the management of refractory TNP. Study Design: The authors present a prospective audit of a novel structured management pathway in the treatment of refractory TNP. Setting: Multidisciplinary facial pain clinic at a University Teaching Hospital. Methods: Over a 4-year period, 70 patients with unilateral TNP were prospectively audited at a tertiary care university hospital. Initial treatment was based on pharmacologic therapy while the patient awaited psychological therapy. Patients who failed to respond were offered a novel set of interventions that included ultrasound-guided trigeminal nerve block with depot steroids. Results: Patient satisfaction with the novel pathway was high. Only 13 patients (13/70, 18%) responded to standard treatment. Of the 57 patients who were offered the novel intervention, 50 patients consented to undergo the intervention. Forty-two patients (42/50, 84%) reported clinically significant pain relief at 3 months, and 27 patients (27/50, 54%) reported on-going durable relief at 6 months. Treatment failure with the novel intervention was 16%. Out of 54 patients in the employable age, 45 patients (45/54, 83%) were able to maintain gainful employment. Limitations: Open-label, nonrandomized observational design. Conclusions: Standard treatment of TNP is ineffective. The novel set of interventions based on empirical evidence may have a role in managing patients with refractory TNP. Key words: Trigeminal neuropathic pain, ultrasound-guided trigeminal nerve block, intermediate cervical plexus block :


2021 ◽  
pp. 105247
Author(s):  
Nontawat Chuinsiri ◽  
David Edwards ◽  
Vsevolod Telezhkin ◽  
Christopher J. Nile ◽  
Fréderic Van der Cruyssen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document